Technivie Interactions
There are 717 drugs known to interact with Technivie (ombitasvir/paritaprevir/ritonavir), along with 7 disease interactions, and 3 alcohol/food interactions. Of the total drug interactions, 274 are major, 401 are moderate, and 42 are minor.
- View all 717 medications that may interact with Technivie
- View Technivie alcohol/food interactions (3)
- View Technivie disease interactions (7)
Most frequently checked interactions
View interaction reports for Technivie (ombitasvir / paritaprevir / ritonavir) and the medicines listed below.
- Actemra (tocilizumab)
- Adasuve (loxapine)
- Adcirca (tadalafil)
- Advate (antihemophilic factor)
- Aldurazyme (laronidase)
- Amicar (aminocaproic acid)
- Aptivus (tipranavir)
- Arixtra (fondaparinux)
- Austedo (deutetrabenazine)
- Azactam (aztreonam)
- Banzel (rufinamide)
- Baraclude (entecavir)
- Baxdela (delafloxacin)
- Biaxin XL (clarithromycin)
- Braftovi (encorafenib)
- Buphenyl (sodium phenylbutyrate)
- Cabometyx (cabozantinib)
- cannabis
- Cardizem (diltiazem)
- Incivek (telaprevir)
- Marplan (isocarboxazid)
- Moderiba (ribavirin)
- PegIntron (peginterferon alfa-2b)
- Procysbi (cysteamine)
- Prolia (denosumab)
- Stivarga (regorafenib)
- Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil)
- Synagis (palivizumab)
- Victrelis (boceprevir)
- Yescarta (axicabtagene ciloleucel)
Technivie alcohol/food interactions
There are 3 alcohol/food interactions with Technivie (ombitasvir / paritaprevir / ritonavir).
Technivie disease interactions
There are 7 disease interactions with Technivie (ombitasvir / paritaprevir / ritonavir) which include:
- immunosuppression
- hepatic dysfunction
- hemophilia
- hyperglycemia
- hyperlipidemia
- heart block
- hepatotoxicity
Report options
More about Technivie (ombitasvir / paritaprevir / ritonavir)
- Technivie consumer information
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antiviral combinations
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Epclusa
Epclusa treats chronic hepatitis C in adults and children 3+. This once-daily antiviral combines ...
Harvoni
Harvoni is used to treat hepatitis C virus (HCV) infections in adults and children aged 3 years and ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Mavyret
Mavyret (glecaprevir/pibrentasvir) is an oral combination medicine containing fixed doses of two ...
Sovaldi
Sovaldi (sofosbuvir) is used to treat chronic hepatitis C virus (HCV) infection. Includes Sovaldi ...
Pegasys
Pegasys is used to treat chronic hepatitis B or C. Learn about side effects, interactions and ...
Vosevi
Vosevi (sofosbuvir,velpatasvir and voxilaprevir) is used to treat chronic hepatitis C. Includes ...
Glecaprevir/pibrentasvir
Glecaprevir/pibrentasvir (Mavyret) is an oral combination medicine containing fixed doses of 2 ...
Interferon alfa-2b
Interferon alfa-2b systemic is used for angioblastoma, condylomata acuminata, conjunctival ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
